2025. Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s630. DOI:https://doi.org/10.25251/ej4zcr36.